Literature for enalapril (XM02.001 inhibitor)

(Topics flags: S Structure, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2013
1. Dalpiaz,P.L.M., Lamas,A.Z., Caliman,I.F., Medeiros,A.R.S., Abreu,G.R., Moyses,M.R., Andrade,T.U., Alves,M.F., Carmona,A.K. and Bissoli,N.S.
   The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats
   Braz J Med Biol Res46, 171-177. PubMed  Europe PubMed  I
2004
2. [YEAR:13-7-2004]Natesh,R., Schwager,S.L., Evans,H.R., Sturrock,E.D. and Acharya,K.R.
   Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme
   Biochemistry43, 8718-8724. PubMed  Europe PubMed DOI  S  I
1985
3. Patchett,A.A. and Cordes,E.H.
   The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme
   Adv Enzymol Relat Areas Mol Biol57, 1-84. PubMed  Europe PubMed  V  I
1984
4. Bunning,P.
   Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat
   Arzneimittelforschung34, 1406-1410. PubMed  Europe PubMed  I
5. [YEAR:15-4-1984]Reynolds,C.H.
   Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid
   Biochem Pharmacol33, 1273-1276. PubMed  Europe PubMed DOI  I
6. [YEAR:23-10-1984]Shapiro,R. and Riordan,J.F.
   Inhibition of angiotensin converting enzyme: mechanism and substrate dependence
   Biochemistry23, 5225-5233. PubMed  Europe PubMed  I
7. [YEAR:23-10-1984]Shapiro,R. and Riordan,J.F.
   Inhibition of angiotensin converting enzyme: dependence on chloride
   Biochemistry23, 5234-5240. PubMed  Europe PubMed  I